Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15613940Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$8M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#511
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Jeffrey Reich as a PI. Multi-PI records show the full award amount for context.
- 5UG3DA058553-02UG3Development of sigma receptor/DAT dual-targeting compounds to treat stimulant use disorder$4Maward amount
- 1UG3DA059278-01A1UG3Development of SBS-226, a MOR agonist / DOR antagonist, for OUD$4Maward amount
Award organization
Organizations that administered FY2024 awards listing Jeffrey Reich as a PI.
FY2024 award administered by Sparian Biosciences, Inc. (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardSparian Biosciences, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #511
- 2024Entered Top 25% NationallyRanked #511
- 2024Entered Top 10% NationallyRanked #511
- 2024Entered Top 5% NationallyRanked #511
- 2025$10M Cumulative Funding